Alissa R. Kahn

489 total citations
6 papers, 227 citations indexed

About

Alissa R. Kahn is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Alissa R. Kahn has authored 6 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pediatrics, Perinatology and Child Health and 2 papers in Infectious Diseases. Recurrent topics in Alissa R. Kahn's work include Acute Myeloid Leukemia Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Alissa R. Kahn is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). Alissa R. Kahn collaborates with scholars based in United States, Switzerland and Spain. Alissa R. Kahn's co-authors include Dan Gazit, R Gibbons, Steve Perkins, Sukru Emre, Benjamin L. Shneider, Roberto Posada, Betsy C. Herold, Rebecca Pellett Madan, Birte Wistinghausen and Nanda Kerkar and has published in prestigious journals such as Transplantation, Cancer Letters and Pediatric Blood & Cancer.

In The Last Decade

Alissa R. Kahn

6 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alissa R. Kahn United States	6	91	61	56	56	37	6	227
Sara Taha Egypt	9	40 0.4×	66 1.1×	44 0.8×	44 0.8×	44 1.2×	48	254
Maria Cancio United States	9	40 0.4×	57 0.9×	22 0.4×	52 0.9×	27 0.7×	31	289
Adina E. Schneider United States	7	55 0.6×	28 0.5×	160 2.9×	28 0.5×	29 0.8×	9	329
Jacques G. Rivière Spain	9	19 0.2×	49 0.8×	36 0.6×	62 1.1×	29 0.8×	35	252
Yamac Akgun United States	4	24 0.3×	117 1.9×	28 0.5×	47 0.8×	76 2.1×	11	288
Swati Sharma India	7	58 0.6×	14 0.2×	39 0.7×	23 0.4×	74 2.0×	70	247
Tommaso Bellini Italy	11	71 0.8×	101 1.7×	37 0.7×	25 0.4×	225 6.1×	41	407
Peter Weiser United States	7	27 0.3×	83 1.4×	46 0.8×	18 0.3×	63 1.7×	13	327
Mireia López-Corbeto Spain	7	39 0.4×	86 1.4×	30 0.5×	32 0.6×	29 0.8×	17	241
Adele Civino Italy	8	27 0.3×	14 0.2×	49 0.9×	15 0.3×	73 2.0×	25	299

Countries citing papers authored by Alissa R. Kahn

Since Specialization

Citations

This map shows the geographic impact of Alissa R. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alissa R. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alissa R. Kahn more than expected).

Fields of papers citing papers by Alissa R. Kahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alissa R. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alissa R. Kahn. The network helps show where Alissa R. Kahn may publish in the future.

Co-authorship network of co-authors of Alissa R. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Alissa R. Kahn. A scholar is included among the top collaborators of Alissa R. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alissa R. Kahn. Alissa R. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kahn, Alissa R., et al.. (2022). COVID-19 in Children with Cancer. Current Oncology Reports. 24(3). 295–302. 16 indexed citations

2.

Pierro, Joanna, D. P. Kothari, Burton Appel, et al.. (2020). Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience. Pediatric Blood & Cancer. 68(3). e28843–e28843. 68 indexed citations

3.

Pera, Benet, M. Nieves Calvo-Vidal, Srikanth Ambati, et al.. (2015). High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells. Cancer Letters. 368(1). 97–104. 10 indexed citations

4.

Madan, Rebecca Pellett, Andrew Campbell, Gail F. Shust, et al.. (2009). A Hybrid Strategy for the Prevention of Cytomegalovirus-Related Complications in Pediatric Liver Transplantation Recipients. Transplantation. 87(9). 1318–1324. 45 indexed citations

5.

Kahn, Alissa R., R Gibbons, Steve Perkins, & Dan Gazit. (1995). Age-related bone loss. A hypothesis and initial assessment in mice.. PubMed. 69–75. 81 indexed citations

6.

Kahn, Alissa R., et al.. (1981). High-dose human leukocyte interferon trials in leukemia and cancer.. PubMed. 9(1). 82–82. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact